Fear of disease progression in adult ambulatory patients with brain cancer: prevalence and clinical correlates
- 33 Downloads
Fear of progression (FoP) is frequent in patients with cancer and of high clinical relevance. Despite the often devastating prognosis of brain cancer, FoP has not yet been assessed in neurooncological patients.
The aim of this study was thus the assessment of FoP and its clinical correlates.
In an ambulatory setting, 42 patients with a primary brain tumour completed the Fear of Progression questionnaire FoP-Q-12. Clinical correlates of FoP were assessed via a variety of measures, including patients’ physical state (Karnofsky Performance Status, KPS), cancer-related psychosocial distress (Distress Thermometer, DT), anxiety (General Anxiety Disorder Scale, GAD-7), depression (Patient Health Questionnaire, PHQ-9), Quality of Life (Short Form Health Survey, SF-8), and unmet supportive care needs (Supportive Care Needs Survey, SCNS).
Eighteen patients (42%) suffered from high FoP (i.e. scored ≥ 34 in the FoP-Q-12). According to the 12 items of the FoP-Q-12, the greatest fears were worrying about what would happen to their family and being afraid of severe medical treatments. No sociodemographic variables (e.g. age, gender) or medical tumour characteristics (e.g. tumour malignancy, first or recurrent tumour) were related to FoP. Patients with more severe physical symptoms reported higher FoP. Patients with higher FoP were more anxious, more depressed, reported lower Quality of Life, and suffered from more unmet supportive care needs.
Our results demonstrate that FoP is frequent and of high clinical relevance for neurooncological patients. Its assessment is not sufficiently covered by instruments for assessment of other areas of psychological morbidity (e.g. general anxiety). Moreover, FoP cannot be predicted by objective characteristics of the patients and disease. Thus, the routine screening for FoP is recommended in neurooncological patients. Clinicians should bear in mind that patients with high FoP are likely to suffer from high emotional distress and unmet supportive care needs and initiate treatment accordingly.
KeywordsBrain tumour Fear of cancer progression Cancer Recurrence Psychooncology Neurooncology
The authors are grateful to Anja Mehnert for providing the SCNS and to Hannah Schmale for the valuable support during data collection.
Compliance with ethical standards
This study was performed in accordance with the Helsinki standard and approved by the local ethics committee.
Conflict of interest
The authors declare that they have no conflict of interest.
We have full control of all primary data and agree to allow the journal to review the data if requested.
- 13.Herschbach P, Berg P, Dankert A, Duran G, Engst-Hastreiter U, Waadt S, Keller M, Ukat R, Henrich G (2005) Fear of progression in chronic diseases: psychometric properties of the Fear of Progression Questionnaire. J Psychosom Res 58:505–511. https://doi.org/10.1016/j.jpsychores.2005.02.007 CrossRefGoogle Scholar
- 18.Sarkar S, Scherwath A, Schirmer L, Schulz-Kindermann F, Neumann K, Kruse M, Dinkel A, Kunze S, Balck F, Kröger N, Koch U, Mehnert A (2014) Fear of recurrence and its impact on quality of life in patients with hematological cancers in the course of allogeneic hematopoietic SCT. Bone Marrow Transplant 49:1217–1222. https://doi.org/10.1038/bmt.2014.139 CrossRefGoogle Scholar
- 22.Sarkar S, Sautier L, Schilling G, Bokemeyer C, Koch U, Mehnert A (2015) Anxiety and fear of cancer recurrence and its association with supportive care needs and health-care service utilization in cancer patients. J Cancer Surviv 9:567–575. https://doi.org/10.1007/s11764-015-0434-2 CrossRefGoogle Scholar
- 25.Shim E-J, Shin Y-W, Oh D-Y, Hahm BJ (2010) Increased fear of progression in cancer patients with recurrence. Gen Hosp Psychiatry 32:169–175. https://doi.org/10.1016/j.genhosppsych.2009.11.017 CrossRefGoogle Scholar
- 31.Löwe B, Spitzer RL, Zipfel S, Herzog W (2000) Der Gesundheitsfragebogen für Patienten (PHQ-D). Manual und TestunterlagenGoogle Scholar
- 33.Ware JE, Kosinski M, Dewey JE, Gandek B, Ware JE, Kisinski M, Ware J, Dewey J (2008) How to score and interpret single-item health status measures. A manual for users of the SF-8™ Health SurveyGoogle Scholar
- 34.Bonevski B, Sanson-Fisher R, Girgis A, Burton L, Cook P, Boyes A, the Supportive Care Review Group (2000) Evaluation of an instrument to assess the needs of patients with cancer. Cancer 88:217–225. https://doi.org/10.1002/(SICI)1097-0142(20000101)88:1<217:AID-CNCR29>3.0.CO;2-Y CrossRefGoogle Scholar